Skip to main content
. 2020 Sep 1;164(3):512–518. doi: 10.1177/0194599820954825

Table 1.

Demographic and Clinical Characteristics of the Patients During the Acute Phase of COVID-19.a

Total (N = 655) Online patients (n = 545) Inpatients (n = 110)
Age, mean ± SD, y 37.7 ± 10.4 36.4 ± 9.1 43.7 ± 13.7
Male sex 231 (35.3) 184 (33.8) 47 (42.7)
White race 493 (75.3) 438 (80.4) 55 (50)
Educational level
 Less than middle school 10 (1.5) 0 10 (9.1)
 Middle school 10 (1.5) 2 (0.4) 8 (7.3)
 Some high school 6 (0.9) 0 6 (5.5)
 High school 61 (9.3) 27 (5) 34 (30.9)
 Some college 41 (6.3) 28 (5.1) 13 (11.8)
 Bachelor or higher 527 (80.5) 488 (89.5) 39 (35.4)
Smoker
 Former 105 (16) 81 (14.9) 24 (21.8)
 Current 18 (2.8) 17 (3.1) 1 (0.9)
NOSE-p3 score, mean ± SD 4.9 ± 4.5 4.6 ± 4.3 6.4 ± 5.4
Comorbidities
 Yes 251 (38.3) 192 (35.2) 59 (53.6)
 Hypertension 55 (8.4) 45 (8.3) 10 (9.1)
 Diabetes 19 (2.9) 13 (2.4) 6 (5.5)
 Asthma 11 (1.7) 8 (1.5) 3 (2.7)
 Dyslipidemia 22 (3.4) 15 (2.8) 7 (6.4)
 Cardiopathy 12 (1.8) 9 (1.6) 3 (2.7)
 Gastroesophageal reflux 11 (1.7) 10 (1.8) 1 (0.9)
General symptoms
 Dyspnea 210 (32.1) 142 (26.1) 68 (61.8)
 Fever 352 (53.7) 274 (50.3) 78 (70.9)
 Digestive 288 (43.9) 248 (45.5) 40 (36.4)
Invasive ventilation 14 (2.1) 1 (0.2) 14 (12.7)
ICU admission 36 (5.5) 12 (2.2) 24 (21.8)
Interval onset symptoms and interview, median (IQR), d 15 (10-24) 16 (10-24) 13 (8-24)

Abbreviations: ICU, intensive care unit; IQR, interquartile range; NOSE-p3, Nasal Obstruction Symptom Evaluation–Portuguese Version No. 3.

a

Values are presented as No. (%) unless noted otherwise.